 |
Click here for
NJ Preventive Cardiology practice brochure
|
Mentoring Program |
|
The Million Hearts
Initiative

For Physicians:
Practical Tips for
Clinicians

For Communities:
Heart2Heart Talk

For Employers and Employees:
You and Health Reform

|
|
|
 |
|  | ACCEPT Clinical System 2011   
Healthcare reform and heart disease and stroke prevention are driven by data. Clinical outcomes and reduced consumption of expensive healthcare resources depend on successfully reaching treatment goals.
 
Drs. Rolando and Emil deGoma presented their performance data using ACCEPT system for cholesterol and cardiovascular risk management in the annual national meeting of the Society of General Internal Medicine in 2006.
Overall, 85% of high risk patients (89% of men and 78% of women) were treated of an LDL goal less than 100. This is superior to 4 other published data.


Detailed comparison of the LDL cholesterol level distribution between L-TAP study and Dr. deGoma's practice.
The difference is marked. In L-TAP only 18% (green) were treated successfully, compared to 85% using ACCEPT. ACCEPT is an acronym for A Cholesterol Clinic in Every Practice. With over 40 million high risk Americans eligible for treatment, the only way to treat such a large number to target goals is to empower all adult medical practices to become basic cholesterol clinics by educating physicians and providing them with a practical, MD-friendly, cost-effective management system.
ACCEPT System for all risk factor management - lipids, hypertension, diabetes and lifestyle modification.
|  |
|
Emil M. deGoma, MD, FACC
Medical Director,
UPenn Preventive
Cardiovascular Program
|
Health Premium Discount |
Lower your risk for heart attack and stroke
using evidence-based therapies and become
eligible for a substantial premium discount by
2014.
 |
|
 |
|
|
Health Reform 2010 |
Prevention and Wellness Summary Provisions
 |
|
 |
|
|
Relay Health |
Contact Office for Non-Urgent Matters
 |
|
 |
|
We Support
Million Hearts Initiative
497,470 Preventable CHD Deaths
Annually with
Evidence-based Medical Therapy
JAMA: 38% of Nonacute
Stents Called into Question
Optimal Medical Therapy Still Underused in
CHD
Legacy Effects
of Statin Therapy - Reduction in
All-Cause Mortality
SG2 Expert Talks About Resetting
Priorities in Cardiology
AHA: Get With The Guidelines - Not Much
Improvement
AIM-HIGH Trial -
Take Home
Message
|